Protective effect of cannabinoid CB1 receptor activation against altered intrinsic repetitive firing properties induced by Aβ neurotoxicity

Neuroscience Letters

Volumn 507, Issue 1, 2012, Pages 33-37

  Haghani, Masoud ^a   Janahmadi, Mahyar ^a   Shabani, Mohammad ^b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Afterhyperpolarization; Alzheimer's disease; Amyloid beta; CA1 pyramidal neurons; Cannabinoid CB1 receptor; Intrinsic properties

Indexed keywords

AMYLOID BETA PROTEIN; CANNABINOID 1 RECEPTOR; CANNABINOID 1 RECEPTOR AGONIST;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ELECTROPHYSIOLOGY; HIPPOCAMPAL CA1 REGION; IN VIVO STUDY; MALE; NEUROTOXICITY; NONHUMAN; PATCH CLAMP; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; WHOLE CELL;

ACTION POTENTIALS; AMYLOID BETA-PEPTIDES; ANIMALS; BIOLOGICAL CLOCKS; CELLS, CULTURED; MALE; NEUROPROTECTIVE AGENTS; NEUROTOXINS; PYRAMIDAL CELLS; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1;

EID: 84855186855     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2011.11.044     Document Type: Article

References (44)

1. Abdi A., Sadraie H., Dargahi L., Khalaj L., Ahmadiani A. Apoptosis inhibition can be threatening in Aβ-induced neuroinflammation, through promoting cell proliferation. Neurochem. Res. 2011, 36:39-48.
2. Blitzer R.D., Wong T., Nouranifar R., Landau E.M. The cholinergic inhibition of afterhyperpolarization in rat hippocampus is independent of cAMP-dependent protein kinase. Brain Res. 1994, 646:312-314.
3. Bojarski L., Herms J., Kuznicki J. Calcium dysregulation in Alzheimer's disease. Neurochem. Int. 2008, 52:621-633.
4. Carter J., Lippa C.F. Beta-amyloid, neuronal death and Alzheimer's disease. Curr. Mol. Med. 2001, 1:733-737.
5. Demuro A., Mina E., Kayed R., Milton S.C., Parker I., Glabe C.G. Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. J. Biol. Chem. 2005, 280:17294-17300.
6. Disterhoft J.F., Thompson L.T., Moyer J.R., Mogul D.J. Calcium-dependent afterhyperpolarization and learning in young and aging hippocampus. Life Sci. 1996, 59:447-457.
7. Esposito G., De Filippis D., Maiuri M.C., De Stefano D., Carnuccio R., Iuvone T. Cannabidiol inhibits inducible nitric oxide synthase protein expression and nitric oxide production in beta-amyloid stimulated PC12 neurons through p38 MAP kinase and NF-kappaB involvement. Neurosci. Lett. 2006, 399:91-95.
8. Faber E.S., Sah P. Physiological role of calcium-activated potassium currents in the rat lateral amygdala. J. Neurosci. 2002, 22:1618-1628.
9. Fan S.F., Yazulla S. Reciprocal inhibition of voltage-gated potassium currents (IK(V)) by activation of cannabinoid CB1 and dopamine D1 receptors in ON bipolar cells of goldfish retina. Vis. Neurosci. 2005, 22:55-63.
10. Fuster J.M. The Prefrontal Cortex: Anatomy, Physiology and Neuropsychology of the Frontal Lobe 1997, Lippincott-Raven, Philadelphia.
11. Gonzalo-Ruiz A., Sanz J.M., Arévalo J., Geula C., Gonzalo P. Amyloid beta peptide-induced cholinergic fibres loss in the cerebral cortex of the rat is modified by diet high in lipids and by age. J. Chem. Neuroanat. 2005, 29:31-48.
12. Gonzalo-Ruiz A., Pérez J.L., Sanz J.M., Geula C., Arévalo J. Effects of lipids and aging on the neurotoxicity and neuronal loss caused by intracerebral injections of the amyloid-beta peptide in the rat. Exp. Neurol. 2006, 197:41-55.
13. Gu N., Vervaeke K., Storm J.F. BK potassium channels facilitate high-frequency firing and cause early spike frequency adaptation in rat CA1 hippocampal pyramidal cells. J. Physiol. 2007, 580:859-882.
14. Gustafsson B. Afterhyperpolarization and the control of repetitive firing in spinal neurons of the cat. Acta Physiol. Scand. Suppl. 1974, 416:1-47.
15. Jung C.G., Uhm K.O., Miura Y., Hosono T., Horike H., Khanna K.K., Kim M.J., Michikawa M. Beta-amyloid increases the expression level of ATBF1 responsible for death in cultured cortical neurons. Mol. Neurodegener. 2011, 6:47.
16. Kim S.H., Won S.J., Mao X.O., Jin K., Greenberg D.A. Molecular mechanisms of cannabinoid protection from neuronal excitotoxicity. Mol. Pharmacol. 2006, 69:691-696.
17. Klafki H.W., Staufenbiel M., Kornhuber J., Wiltfang J. Therapeutic approaches to Alzheimer's disease. Brain 2006, 129:2840-2855.
18. Kumar A., Bodhinathan K., Foster T.C. Susceptibility to calcium dysregulation during brain aging. Front. Aging Neurosci. 2009, 1:2.
19. 2+-dependent afterhyperpolarizations in hippocampal neurons of aged rats. Science 1984, 226:1089-1092.
20. Larner A.J. Epileptic seizures in AD patients. Neuromol. Med. 2010, 12:71-77.
21. Ma M., Koester J. Consequences and mechanisms of spike broadening of R20 cells in Aplysia californica. J. Neurosci. 1995, 15:6720-6734.
22. Mackie K., Hille B. Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells. Proc. Natl. Acad. Sci. U.S.A. 1992, 89:3825-3829.
23. Matsuda L.A., Lolait S.J., Brownstein M.J., Young A.C., Bonner T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 1990, 34:561-564.
24. Minkeviciene R., Rheims S., Dobszay M.B., Zilberter M., Hartikainen J., Fulop L., Penke B., Zilberter Y., Harkany T., Pitkanen A., Tanila H. Amyloid beta-induced neuronal hyperexcitability triggers progressive epilepsy. J. Neurosci. 2009, 29:3453-3462.
25. Nagayama T., Sinor A.D., Simon R.P., Chen J., Graham S.H., Jin K., Greenberg D.A. Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures. J. Neurosci. 1999, 19:2987-2995.
26. Nakamura S., Murayama N., Noshita T., Katsuragi R., Ohno T. Cognitive dysfunction induced by sequential injection of amyloid-beta and ibotenate into the bilateral hippocampus; protection by memantine and MK-801. Eur. J. Pharmacol. 2006, 548:115-122.
27. 2+ channels. J. Neurosci. 1998, 18:3171-3179.
28. AHP via cyclic AMP-dependent protein kinase in hippocampal neurons. J. Neurophysiol. 1995, 74:2749-2753.
29. AHP by a phosphatase-kinase balance under basal conditions in rat CA1 pyramidal neurons. J. Neurophysiol. 1998, 79:3252-3256.
30. Petrides M. Frontal lobes and working memory: evidence from investigations of the effects of cortical excisions in nonhuman primates. Handbook of Neurophysiology 1994, 59-82. Elsevier, Amsterdam. F.S.F. Boller, J.A. Hendler (Eds.).
31. + channels. Neuropharmacology 1996, 35:983-991.
32. Saint Marie R.L., Miller E.J., Breier M.R., Weber M., Swerdlow N.R. Projections from ventral hippocampus to medial prefrontal cortex but not nucleus accumbens remain functional after fornix lesions in rats. Neuroscience 2010, 168:498-504.
33. Scuri R., Mozzachiodi R., Brunelli M. Activity-dependent increase of the AHP amplitude in T sensory neurons of the leech. J. Neurophysiol. 2002, 88:2490-2500.
34. + channels in spike broadening during repetitive firing in rat hippocampal pyramidal cells. J. Physiol. 1999, 521:135-146.
35. Sinor A.D., Irvin S.M., Greenberg D.A. Endocannabinoids protect cerebral cortical neurons from in vitro ischemia in rats. Neurosci. Lett. 2000, 278:157-160.
36. Smith I.F., Green K.N., LaFerla F.M. Calcium dysregulation in Alzheimer's disease: recent advances gained from genetically modified animals. Cell Calcium 2005, 38:427-437.
37. Sonkusare S.K., Kaul C.L., Ramarao P. Dementia of Alzheimer's disease and other neurodegenerative disorders - memantine, a new hope. Pharmacol. Res. 2005, 51:1-17.
38. Squire L.R. Memory and the hippocampus: a synthesis from findings with rats, monkeys, and human. Psychol. Rev. 1992, 99:195-231.
39. Swanson L.W. A direct projection from Ammon's horn to prefrontal cortex in the rat. Brain Res. 1981, 217:150-154.
40. Thierry A.M., Gioanni Y., Dégénétais E., Glowinski J. Hippocampo-prefrontal cortex pathway: anatomical and electrophysiological characteristics. Hippocampus 2000, 10:411-419.
41. Uhlhaas P.J., Singer W. Neural synchrony in brain disorders: relevance for cognitive dysfunctions and pathophysiology. Neuron 2006, 52:155-168.
42. van der Stelt M., Mazzola C., Esposito G., Matias I., Petrosino S., De Filippis D., Micale V., Steardo L., Drago F., Iuvone T., Di Marzo V. Endocannabinoids and beta-amyloid-induced neurotoxicity in vivo: effect of pharmacological elevation of endocannabinoid levels. Cell. Mol. Life Sci. 2006, 63:1410-1424.
43. Wang Y., Zhang G., Zhou H., Barakat A., Querfurth H. Opposite effects of low and high doses of Abeta42 on electrical network and neuronal excitability in the rat prefrontal cortex. PLoS One 2009, 4:e8366.
44. Yun S.H., Gamkrelidze G., Stine W.B., Sullivan P.M., Pasternak J.F., Ladu M.J., Trommer B.L. Amyloid-beta1-42 reduces neuronal excitability in mouse dentate gyrus. Neurosci. Lett. 2006, 403:162-165.